(S)-Lenalidomide
(S)-3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
Product summary
Quick view
- Product family
- PROTAC, E3 Ligands & Proximity-Inducing Building Blocks
- Chemical Name
- (S)-3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
- MF
- C13H13N3O3
- MW
- 259.26
(S)-Lenalidomide is the S-enantiomer of lenalidomide listed with CAS 202271-91-8.
PubChem, ChemicalBook, and the CHEMOS catalog support formula C13H13N3O3 and molecular weight 259.26.
The public identity connects this compound with lenalidomide stereochemical nomenclature and molecular-glue literature indexing.
Identity and specifications
| Catalog No. | CH57010 |
| CAS No. | 202271-91-8 |
| Product Name | (S)-Lenalidomide |
| Chemical Name | (S)-3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione |
| IUPAC Name | (3S)-3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione |
| Synonyms | S-Lenalidomide; Lenalidomide, (S)-; (3S)-3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione |
| Molecular Formula | C13H13N3O3 |
| Molecular Weight | 259.26 |
| PubChem CID | 12044976 |
| InChIKey | GOTYRUGSSMKFNF-JTQLQIEISA-N |
| Isomeric SMILES | C1CC(=O)NC(=O)[C@H]1N2CC3=C(C2=O)C=CC=C3N |
Application context
- S-enantiomer identity: connects CAS 202271-91-8 with (S)-Lenalidomide and the corresponding stereochemical IUPAC name.
- Structure reference: PubChem CID 12044976 provides the formula, molecular weight, InChIKey, and isomeric SMILES used for identity matching.
- Literature category context: PubMed-indexed lenalidomide records appear in molecular-glue research discussions; CH57010 is presented as a stereochemical identity record.
Additional material information
Characteristics
- S-enantiomer identity for lenalidomide, CAS 202271-91-8.
- Formula C13H13N3O3 and molecular weight 259.26 are supported by PubChem, ChemicalBook, and CHEMOS.
- PubChem CID 12044976 provides the stereochemical identifier used in this page.
Related technical resources
PROTAC / TPD Building Blocks
CRBN and VHL ligand derivatives, ligand-linkers, bifunctional degrader intermediates, and linker-tuning building blocks.
PROTAC Linker Selection
Build linker series from both ligands, exit vectors, ternary-complex geometry, conformation, permeability, synthesis, and assay evidence.
Public references
- Lenalidomide, (S)- | PubChem CID 12044976
- Catalytic in vivo protein knockdown by small-molecule PROTACs
Nature Chemical Biology, 2015
Product-family technical context
- Structural basis of PROTAC cooperative recognition for selective protein degradation
Nature Chemical Biology, 2017
Product-family technical context
- Structural Basis of PROTAC Cooperative Recognition for Selective Protein Degradation
Nature Chemical Biology, 2017
Product-family technical context
- Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation
ACS Medicinal Chemistry Letters, 2022
Product-family technical context
Similar Products
Need Help with Material Selection?
CHEMOS can review product fit, target structure, route questions, analytical expectations, and project-specific supply needs.